Home » Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Novartis to Add Warnings to Rasilez Blood-Pressure Drug
Novartis AG said it will add a warning to the label for its blood-pressure drug Rasilez in Europe to comply with a request from regulators.
Bloomberg
Bloomberg
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May